Nafamostat 6-甲脒基萘-2-基 4-胍基苯甲酸酯
CAS 81525-10-2 MFCD00866067
化学结构图
SMILES: NC(=N)C1=CC2=CC=C(C=C2C=C1)OC(=O)C1C=CC(=CC=1)NC(N)=N
化学属性
| Mol. Formula | C19H17N5O2 |
|---|---|
| Mol. Weight | 347.376 |
别名和识别编码
| Chemical Name | Nafamostat |
|---|---|
| Chemical Name Translation | 6-甲脒基萘-2-基 4-胍基苯甲酸酯 |
信息真实价格透明
资金保障
专业采购外包团队在线服务
信息真实价格透明
资金保障
专业采购外包团队在线服务
品牌质保精细包装
现货库存
一流品牌服务
相关文献及参考
- [2]. Homma S, et al. Nafamostat mesilate, a serine protease inhibitor, suppresses interferon-gamma-induced up-regulation of programmed cell death ligand 1 in human cancer cells. Int Immunopharmacol. 2018 Jan;54:39-45.
- [3]. Pak K, et al. Effectiveness of FUT-175, protease inhibitor, as an anticoagulant to hemodialysis. Hinyokika Kiyo. 1988 Jun;34(6):1077-81.
- [4]. Markus Hoffmann, et al. Nafamostat Mesylate Blocks Activation of SARS-CoV-2: New Treatment Option for COVID-19. Antimicrob Agents Chemother. 2020 Jun; 64(6): e00754-20.
- [1]. Ikehara S, et al. Effect of FUT-175, a new synthetic protease inhibitor, on the development of lupus nephritis in (NZB x NZW) F1 mice. Immunology. 1985 Aug;55(4):595-600.
- [1]. Ikehara S, et al. Effect of FUT-175, a new synthetic protease inhibitor, on the development of lupus nephritis in (NZB x NZW) F1 mice. Immunology. 1985 Aug;55(4):595-600.
- [2]. Homma S, et al. Nafamostat mesilate, a serine protease i
京ICP备2020036287号